Hepatitis B vaccine - An urgent need of re-appraisal

Sunday 7 November 2004 by Marc Girard

Further a recent publication on the risk of multiple sclerosis after hepatitis B vaccine, this paper summarizes evidence pointing to an unusual toxicity of this vaccine. Due to selective biases in the production and dissemination of information, the remarkable frequency, severity and variety of HBV complications has been overlooked. An urgent reappraisal of the benefit/risk ratio of this preventive medicine is now required.